---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-037615"
form_type: "8-K"
ticker: "TMDX"
cik: "0001756262"
company_name: "TransMedics Group, Inc."
filed_at: "2026-02-04T23:59:59+00:00"
generated_at: "2026-05-16T04:58:37.608808+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# TransMedics appoints new CCO and new General Counsel in leadership transition

## Summary
- Giovanni Cecere appointed Chief Commercial Officer effective Feb 2, 2026, succeeding Tamer Khayal who becomes SVP International.
- Matthew Forsyth appointed SVP, General Counsel & Corporate Secretary effective March 9, 2026, succeeding Anil Ranganath.
- Anil Ranganath transitions to non-executive employee until June 7, 2026, then consultant through Sept 7, 2026; retains base salary and equity vesting.
- Ranganath eligible for severance of 0.75x highest salary+bonus, COBRA for 9 months, and pro-rated 2026 bonus subject to release.

## SEC filing metadata
- accession: 0001193125-26-037615
- form_type: 8-K
- ticker: TMDX
- cik: 0001756262
- company_name: TransMedics Group, Inc.
- filed_at: 2026-02-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1756262/000119312526037615/0001193125-26-037615-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1756262/000119312526037615/d50302d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-037615
- JSON: https://secwatch.observer/filing/0001193125-26-037615.json
- Plain text: https://secwatch.observer/filing/0001193125-26-037615.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.